AI Insight: Charles River Laboratories is trading 31.2% above a high-confidence fair value of $158.77, indicating potential overvaluation. Financial health scores reveal significant weaknesses in profitability and efficiency, while Monte Carlo analysis shows high downside risk (94.4%) and substantial volatility (42.44% coefficient of variation). These factors suggest elevated investment risk amid uncertain growth prospects.